Healthcare -
Biotechnology - NASDAQ - US
$ 103.32
-3.21 %
$ 9.87 B
Market Cap
44.15
P/E
SRPT - ACCOUNTS PAYABLE
Accounts Payable SRPT - Sarepta Therapeutics, Inc.
165 M
LAST VALUE
46.60%
2 YEAR CAGR
37.28%
5 YEAR CAGR
25.05%
10 YEAR CAGR